Funder: National Institutes of Health
Due Dates: February 14, 2025 (New/Renewal/Resubmission/Revision) | February 2, 2026 (New/Renewal/Resubmission/Revision) | June 15, 2027 (New/Renewal/Resubmission/Revision)
Funding Amounts: ~$2.4M/year total for 2–4 awards; budgets not limited but must reflect actual project needs; max project period 5 years.
Summary: Supports resource-limited and IDeA-eligible institutions to scale up production and distribution of brain cell type-specific access/manipulation reagents for broad use in neuroscience.
Key Information: Limited to RLIs and IDeA-eligible institutions; clinical trials not allowed; strong emphasis on collaboration with BRAIN Armamentarium projects.